N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-glutamic acid
RxNorm 13904
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 13904 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-glutamic acid.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Dichloromethotrexate
(Atom ID: 2064102)
FN
Full form of descriptor (FN):
Dichloromethotrexate (substance)
(Atom ID: 2064103)
SY